0,846  0,003  P-glycoprotein inhibitor
0,825  0,004  Antineoplastic (pancreatic cancer)
0,751  0,004  Antiparasitic
0,741  0,003  Antihelmintic
0,711  0,004  Antifungal
0,719  0,016  Antineoplastic (lung cancer)
0,704  0,004  Antineoplastic (lymphoma)
0,693  0,032  Antiinflammatory
0,642  0,014  Antibacterial
0,641  0,029  Antineoplastic (breast cancer)
0,631  0,019  Antineoplastic (colon cancer)
0,632  0,020  Antineoplastic (colorectal cancer)
0,605  0,014  Atherosclerosis treatment
0,586  0,015  Immunosuppressant
0,562  0,008  Antineoplastic (glioblastoma multiforme)
0,548  0,003  Antifungal enhancer
0,584  0,053  Apoptosis agonist
0,532  0,004  Antineoplastic antibiotic
0,538  0,014  Antineoplastic (glioma)
0,532  0,020  Antineoplastic (melanoma)
0,537  0,028  Antiprotozoal
0,509  0,007  Interleukin 2 agonist
0,498  0,001  Cyclophilin A inhibitor
0,480  0,003  Antihelmintic (Nematodes)
0,486  0,010  Wound healing agent
0,459  0,008  Antineoplastic (squamous cell carcinoma)
0,476  0,028  Cytotoxic
0,469  0,031  Antiprotozoal (Plasmodium)
0,418  0,018  Antineoplastic enhancer
0,393  0,019  Sodium/bile acid cotransporter inhibitor
0,403  0,032  Antineoplastic (non-small cell lung cancer)
0,373  0,003  Acetyl-CoA transferase inhibitor
0,422  0,055  Antineoplastic (myeloid leukemia)
0,398  0,037  CTGF expression inhibitor
0,440  0,085  Antineoplastic (solid tumors)
0,377  0,029  Hypolipemic
0,393  0,047  FMO1 substrate
0,378  0,044  Lipoprotein disorders treatment
0,346  0,017  Antineoplastic (carcinoma)
0,347  0,046  Antineoplastic (cervical cancer)
0,322  0,038  Interleukin agonist
0,348  0,066  Prostate cancer treatment
0,306  0,024  VCAM1 expression inhibitor
0,288  0,007  ATPase inhibitor
0,355  0,076  CYP3A4 substrate
0,298  0,025  Protein kinase C nu inhibitor
0,310  0,040  DNA synthesis inhibitor
0,356  0,087  Antipruritic, allergic
0,349  0,081  Antileukemic
0,298  0,032  RNA-directed DNA polymerase inhibitor
0,271  0,008  Antibiotic
0,324  0,064  NOS3 expression inhibitor
0,325  0,064  Antineoplastic (ovarian cancer)
0,327  0,073  Antithrombotic
0,311  0,062  Antineoplastic (endocrine cancer)
0,303  0,068  Antineoplastic (osteosarcoma)
0,289  0,060  Radiosensitizer
0,363  0,135  Caspase 9 stimulant
0,285  0,058  Antineoplastic (liver cancer)
0,303  0,076  Antimycobacterial
0,217  0,003  Antiviral (Hepatitis A)
0,244  0,031  Antiacne
0,300  0,089  ICAM1 expression inhibitor
0,206  0,003  ATPase (Vacuolar H+) inhibitor
0,206  0,003  Antibiotic Glycopeptide-like
0,251  0,050  Anesthetic general
0,221  0,025  Carcinogenic, group 1
0,200  0,005  Antiviral (SARS coronavirus)
0,200  0,005  Antiviral (Coronavirus)
0,215  0,025  Cell wall synthesis inhibitor
0,274  0,088  Metabolic disease treatment
0,253  0,077  Antineoplastic (renal cancer)
0,235  0,065  Antiviral (HIV)
0,204  0,040  Acute respiratory distress syndrome (ARDS) treatment
0,239  0,078  Antineoplastic (sarcoma)
0,272  0,111  Antineoplastic (small cell lung cancer)
0,307  0,147  Antiarthritic
0,231  0,076  Cytostatic
0,247  0,101  Antihypoxic
0,201  0,059  Antiviral (Hepatitis)
0,189  0,049  Antiviral (Hepatitis C)
0,142  0,003  Acetyl-CoA transferase 2 inhibitor
0,168  0,034  Gout treatment
0,215  0,082  Peptidyltransferase inhibitor
0,232  0,100  Chemoprotective
0,220  0,089  Vasodilator
0,206  0,080  Antihypertriglyceridemic
0,230  0,105  Gastrin inhibitor
0,146  0,023  Electron transport complex I inhibitor
0,145  0,024  Protein kinase C delta inhibitor
0,140  0,019  Chymotrypsin inhibitor
0,176  0,056  Uterine stimulant
0,160  0,041  Antiviral (Hepatitis B)
0,182  0,064  Antirickettsial
0,151  0,037  Microtubule formation inhibitor
0,139  0,027  Uric acid excretion stimulant
0,167  0,057  Protein kinase stimulant
0,150  0,042  Ca2+-transporting ATPase inhibitor
0,135  0,027  Interleukin 2 antagonist
0,242  0,135  Apoptosis antagonist
0,152  0,045  Alkylator
0,115  0,008  Antitreponemal
0,112  0,009  Antimycoplasmal
0,231  0,132  AR expression inhibitor
0,202  0,103  Antihypotensive
0,232  0,138  Cholesterol antagonist
0,183  0,092  Pneumotoxic
0,214  0,123  UGT2B4 substrate
0,159  0,068  UGT2B9 substrate
0,177  0,090  Non-steroidal antiinflammatory agent
0,114  0,028  Interleukin 5 antagonist
0,099  0,014  Protein kinase C beta inhibitor
0,099  0,015  Androgen agonist
0,155  0,071  Interferon gamma antagonist
0,088  0,005  Ryanodine receptor antagonist
0,203  0,121  Proliferative diseases treatment
0,223  0,142  Antineoplastic (brain cancer)
0,127  0,047  Protein kinase C gamma inhibitor
0,126  0,047  Nav1.4 sodium channel blocker
0,139  0,062  Alpha-N-acetylglucosaminidase inhibitor
0,091  0,015  Protein 50S ribosomal subunit inhibitor
0,092  0,019  Protein kinase C eta inhibitor
0,073  0,001  Immunosuppressant Cyclosporine-like
0,202  0,133  Analeptic
0,211  0,144  Nootropic
0,142  0,077  Acaricide
0,230  0,167  CYP2C9 substrate
0,078  0,016  Kallikrein 7 inhibitor
0,062  0,008  Acetyl-CoA transferase 1 inhibitor
0,201  0,148  Antineoplastic (multiple myeloma)
0,085  0,033  Prokinetic
0,145  0,094  Hearing loss treatment
0,195  0,145  Tyrosine 3 hydroxylase inhibitor
0,131  0,081  Antiparkinsonian, tremor relieving
0,189  0,141  Respiratory analeptic
0,105  0,056  Anticataract
0,191  0,142  CYP2C19 substrate
0,071  0,024  Protein kinase C epsilon inhibitor
0,100  0,055  Prolactin inhibitor
0,059  0,016  Growth hormone release inhibitor
0,067  0,025  Elastase inhibitor
0,191  0,150  Antiischemic
0,115  0,074  Carcinogenic, group 3
0,057  0,018  Histone deacetylase 8 inhibitor
0,075  0,039  Protein kinase C alpha inhibitor
0,092  0,057  Triose-phosphate isomerase inhibitor
0,132  0,097  Mutagenic
0,079  0,044  Cathepsin G inhibitor
0,044  0,009  Growth factor receptor-bound protein 2 antagonist
0,060  0,026  Alpha-mannosidase inhibitor
0,089  0,055  Tocolytic
0,035  0,002  Calcineurin inhibitor
0,052  0,019  Somatostatin 1 antagonist
0,046  0,014  Somatostatin 5 agonist
0,194  0,164  5 Hydroxytryptamine uptake stimulant
0,038  0,008  Motilin receptor antagonist
0,150  0,122  Angiogenesis stimulant
0,068  0,041  Uterine relaxant
0,211  0,185  Ulceration
0,064  0,039  Transcription factor AP-1 inhibitor
0,127  0,102  NOS3 expression enhancer
0,040  0,015  Tubulin agonist
0,082  0,058  T cell inhibitor
0,100  0,076  GST T1-1 substrate
0,058  0,036  Peristaltic stimulant
0,057  0,035  Bromodomain-containing protein 4 inhibitor
0,078  0,057  Antidote, organophosphates
0,182  0,162  Flavin-containing monooxygenase substrate
0,080  0,061  Antispirochetal
0,103  0,084  Cell adhesion inhibitor
0,071  0,053  Glycine receptor agonist
0,131  0,116  Cystic fibrosis treatment
0,044  0,029  Secretase gamma inhibitor
0,160  0,145  Tumour necrosis factor alpha release inhibitor
0,214  0,200  Antineoplastic (non-Hodgkin's lymphoma)
0,185  0,171  Hypoxia-inducible factor 1 alpha inhibitor
0,155  0,141  Antihypercholesterolemic
0,035  0,023  HMG CoA reductase inhibitor
0,130  0,119  Nitric oxide antagonist
0,044  0,033  Mannosidase inhibitor
0,079  0,071  mTOR complex 2 inhibitor
0,017  0,008  Antibiotic Macrolide-like
0,023  0,016  Motilin receptor agonist
0,035  0,029  Nicotinic receptor beta4 subunit antagonist
0,096  0,091  DNA polymerase I inhibitor
0,129  0,126  Interleukin 6 antagonist
0,026  0,026  1,3-Beta-glucan synthase inhibitor
0,036  0,036  Oxytocin agonist
0,061  0,061  Elastase 1 inhibitor
0,162  0,161  Antiprotozoal (Trypanosoma)

